Clinical Trial Update: A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. [Phase 1]

View source ↗

Summary

Phase 1 study of capecitabine (Xeloda) in combination with oxaliplatin in patients with metastatic colorectal cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-01-08